Clinical and Pathological Comparison of Paratuberculosis and Crohn's Disease
Crohn's disease is a chronic systemic inflammatory condition presenting primarily with gastrointestinal pathology. It is a debilitating disease, which typically leads to weight loss, abdominal pain, diarrhoea and obstruction, among others (Chiodini, 1989).
The diseased tissue in both Crohn's and paratuberculosis is characterized by transmural ulceration, non-caseating granulomas, infiltration of lymphocytes and macrophages, mucosal cobblestoning and creeping mesenteric fat (Chacon et al., 2004). More recent‘Corresponding author: shannon.duffy@mail.mcgill.ca © CAB International 2020. Paratuberculosis: Organism, Disease, Control, 2nd Edition (eds M.A. Behr et al.)
| Table 3.1. Pros. Arguments in favour of the potential aetiological role of Mycobacterium avium subsp. paratuberculosis (MAP) in Crohn's disease. Based on Sartor, 2005. | ||
| Arguments | Responses from emerging data | References |
| 1. Clinical and pathological similarities of paratuberculosis and Crohn's disease | Confirmed | Zarei-Kordshouli et al., 2019 |
| 2. Presence in food chain (milk, meat) and water supplies | Confirmed | Beumer et al., 2010; Carvalho et al., 2012; Rhodes et al., 2014; Espeschit et al., 2018; Gerrard et al., 2018; Lorencova et al., 2019 |
| 3. Increased detection of MAP in Crohn's disease tissues by culture, PCR, FISH | Confirmed | Feller et al., 2007; Abubakar et al., 2008; Waddell et al., 2015 |
| 4. Positive blood cultures of MAP in Crohn's disease patients | Unresolved | Parrish et al., 2009; Mendoza et al., 2010 |
| 5. Increased serological responses to MAP in Crohn's disease patients | Confirmed | Verdier et al., 2013; Xia et al., 2014; Zamani et al., 2017 |
| 6. Therapeutic responses to combination anti-tuberculosis therapy that include macrolide antibiotics | Confirmed | Feller et al., 2010; Khan et al., 2011 |
FISH, fluorescence in situ hybridization; MAP, Mycobacterium avium subsp. paratuberculosis; PCR, polymerase chain reaction.
comparative pathology studies have emphasized that both disease tissues display relatively the same frequency of granulomatous enteritis, lymphoplasmacytic enteritis, oedema and lym- phangiesctasia (Zarei-Kordshouli et al., 2019).
However, differences have been observed between these two conditions. A comparative pathological study between 29 Crohn's disease, 17 ulcerative colitis and 35 bovine paratuberculosis samples described Crohn's disease lesions as more destructive than paratuberculosis, as defined by the degree of damage to the epithelium, ulcer and fissure formation, among others (Momotani et al., 2012). Conversely, a recent study found that vasculitis was observed in nearly all paratuberculosis tissues and only a small percentage of Crohn's disease tissues. The most prominent pathological difference between classical paratuberculosis and Crohn's disease is the ability to readily visualize acid-fast bacteria in the diseased tissue from cattle (Zarei-Kordshouli et al., 2019). The detection of MAP in tissues of humans with Crohn's disease has proven inconsistent or unsuccessful, a fact that will be discussed in more detail in a future section.
Together, these observations demonstrate that the rationale implicating MAP in Crohn's disease is backed by the many similarities with paratuberculosis. However, it is noted that granulomatous pathology is not pathognomonic for a single aetiology; other granulomatous conditions range from a wood splinter to berylliosis and include bacterial infections (e.g. leprosy) and fungal infections (e.g. histoplasmosis). Furthermore, while differences in pathological presentation between paratuberculosis and Crohn's disease might argue against a common aetiological agent, Crohn's disease is generally accepted to develop due to a combination of genetic, immune and environmental factors. Given the differences in genetics, immunology and environmental exposures between humans and cattle, the final clinical and pathological outcomes of a similar microbial exposure need not be identical.
3.3
More on the topic Clinical and Pathological Comparison of Paratuberculosis and Crohn's Disease:
- Paratuberculosis and Crohn's Disease
- The Use of Anti-Mycobacterial Therapy for Treatment of Crohn’s Disease
- Detection of MAP in Crohn’s Disease Patients
- MAP Immune Responses in Crohn’s Disease Patients
- CLINICAL EVALUATION FOR CARDIAC DISEASE
- Behr Marcel A., Stevenson K., Kapur V. (eds.). Paratuberculosis: Organism, Disease, Control. 2nd edition. — CAB International,2020. — 439 p., 2020
- CLINICAL EVALUATION IN NEUROLOGICAL DISEASE
- CLINICAL EVALUATION OF RESPIRATORY DISEASE
- Clinical aspects of HIV disease in developing countries
- CLINICAL EVALUATION OF GIT DISEASE
- Immunology of Paratuberculosis Infection and Disease
- Bacteria play a significant role in clinical disease in the rabbit.